David Wood

Showing 1-17 of 17 articles

Interventions for valvular disease

Repeat transcatheter aortic valve replacement and implications for transcatheter heart valve performance: insights from bench testing

Sathananthan J, Fraser R, Landes U, Rich C, Sellers S, Leipsic J, Blanke P, Lutter G, Frank D, Puehler T, Wood D, Søndergaard L, Webb J

January 26, 2021 | 10.4244/EIJ-D-20-00697

Interventions for valvular disease

Reference dimensions of stented surgical aortic bioprostheses for valve size determination

Anastasius M, Godoy M, Weir-McCall J, Bapat V, Sathananthan J, Hensey M, Sellers S, Cheung A, Ye J, Wood D, Leipsic J, Webb J, Blanke P

August 7, 2020 | 10.4244/EIJ-D-19-00921

“Minimalist” transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity

Wood D, Sathananthan J

August 7, 2020 | 10.4244/EIJV16I6A82

Interventions for valvular disease

A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention

Sathananthan J, Fraser R, Hatoum H, Barlow A, Stanová V, Allen K, Chhatriwalla A, Rieu R, Pibarot P, Dasi L, Søndergaard L, Wood D, Webb J

March 20, 2020 | 10.4244/EIJ-D-19-00939

Interventions for valvular disease

Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions

Sathananthan J, Fraser R, Kütting M, Hensey M, Landes U, Alkhodair A, Sedaghat A, Blanke P, Toggweiler S, Leipsic J, Søndergaard L, Wood D, Webb J

February 7, 2020 | 10.4244/EIJ-D-19-00782

Interventions for valvular disease

Early experience with a purpose-designed temporary pacing guidewire for transcatheter valve implantation

Hensey M, Daniels D, Wood D, Webb J

August 9, 2019 | 10.4244/EIJ-D-19-00138

Interventions for valvular disease

Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study

Sathananthan J, Sellers S, Fraser R, Dvir D, Hensey M, Murdoch D, Blanke P, Pibarot P, Toggweiler S, Wood D, Leipsic J, Webb J

May 20, 2019 | 10.4244/EIJ-D-18-00947

Increasing awareness of the need to protect the coronary arteries in patients with failed surgical and transcatheter aortic valves

Webb J, Sathananthan J, Wood D

May 20, 2019 | 10.4244/EIJV15I1A3

Interventions for valvular disease

First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system

Hensey M, Murdoch D, Sathananthan J, Alenezi A, Sathananthan G, Moss R, Blanke P, Leipsic J, Wood D, Cheung A, Ye J, Webb J

February 7, 2019 | 10.4244/EIJ-D-18-00935

Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and BASILICA

Dvir D, Khan J, Kornowski R, Komatsu I, Chhatriwalla A, Mackensen G, Simonato M, Ribeiro H, Wood D, Leipsic J, Webb J, Mylotte D

September 7, 2018 | 10.4244/EIJ-D-18-00667

Transcatheter or surgical valve replacement: which strategy when bioprosthetic valves fail?

Webb J, Murdoch D, Wood D

November 20, 2017 | 10.4244/EIJV13I10A177

Interventions for valvular disease

Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience

Perlman G, Cheung A, Dumont E, Stub D, Dvir D, Del Trigo M, Pelletier M, Alnasser S, Ye J, Wood D, Thompson C, Blanke P, Leipsic J, Seidman M, LeBlanc H, Buller C, Rodés-Cabau J, Webb J

January 20, 2017 | 10.4244/EIJ-D-16-00299

Interventions for valvular disease

In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves

Simonato M, Azadani A, Webb J, Leipsic J, Kornowski R, Vahanian A, Wood D, Piazza N, Kodali S, Ye J, Whisenant B, Gaia D, Aziz M, Pasala T, Mehilli J, Wijeysundera H, Tchétché D, Moat N, Teles R, Petronio A, Hildick-Smith D, Landes U, Windecker S, Arbel Y, Mendiz O, Makkar R, Tseng E, Dvir D

September 18, 2016 | 10.4244/EIJV12I7A149

Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement

Barbanti M, Binder R, Freeman M, Wood D, Leipsic J, Cheung A, Ye J, Tan J, Toggweiler S, Yang T-H, Dvir D, Maryniak K, Lauck S, Webb J

December 27, 2013 | 10.4244/EIJV9I8A156

Edwards SAPIEN 3 valve

Binder R, Rodés-Cabau J, Wood D, Webb J

September 30, 2012 | 10.4244/EIJV8SQA15

Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines

Gurvitch R, Toggweiler S, Willson A, Wijesinghe N, Cheung A, Wood D, Ye J, Webb J

May 17, 2011 | 10.4244/EIJV7I1A10

Valve thrombosis after transcatheter heart valve implantation

Tay E, Gurvitch R, Wijesinghe N, Nietlispach F, Wood D, Allard M, Munt B, Cheung A, Webb J

May 17, 2011 | 10.4244/EIJV7I1A28

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.